News | Magnetic Resonance Imaging (MRI) | November 17, 2023

University of Minnesota Medical School Researchers Investigate Cause of Cardiomyopathy in Coronary Artery Disease Using Cardiac MRI

Researchers from the University of Minnesota Medical School examining the cause of cardiomyopathy discovered one out of every six patients with coronary artery disease had non-ischemic or dual cardiomyopathy

Getty Images


November 17, 2023 — Researchers from the University of Minnesota Medical School examining the cause of cardiomyopathy discovered one out of every six patients with coronary artery disease had non-ischemic or dual cardiomyopathy.  

The findings of this study were published this week in the peer-reviewed journal Circulation, the flagship journal of the American Heart Association.  

Cardiomyopathies are diseases of the heart muscle. Patients with coronary artery disease can have cardiomyopathy from heart muscle damage as a result of heart attacks. Therefore, in patients with cardiomyopathy, the current clinical practice is to look for coronary artery disease using coronary angiography—an X-ray test that shows whether coronary arteries are narrowed or blocked. If coronary artery disease is found, it is assumed the patient has ischemic cardiomyopathy.  

Non-ischemic cardiomyopathy refers to a heart muscle condition where the cause of the problem is not related to blood supply. Dual cardiomyopathy refers to two simultaneous problems with the heart muscle—both ischemic and non-ischemic. Patients with these conditions had worse long-term outcomes compared with patients with ischemic cardiomyopathy. 

The research team studied patients with coronary artery disease who had cardiac magnetic resonance imaging (CMR) for clinical reasons, which allowed a more accurate determination of the presence and the cause of cardiomyopathy. 

“Investigating the cause of cardiomyopathy using CMR for a myocardium-centric approach—in contrast to the conventional coronary-centric approach using coronary angiography—provided us new insights with important clinical implications,” said Chetan Shenoy, MBBS, MS, senior author of the paper, an associate professor at the University of Minnesota Medical School and a cardiologist with M Health Fairview. “Our findings have implications for the treatment of patients with coronary artery disease and cardiomyopathy, traditionally assumed to all have ischemic cardiomyopathy.” 

The findings imply that in patients with obstructive coronary artery disease, coincidental non-ischemic or dual cardiomyopathy may contribute to the lack of prognostic benefit from coronary revascularization—procedures which restore blood flow to areas of the heart that are not getting enough blood. 

Future research should investigate whether non-ischemic or dual cardiomyopathy in patients with coronary artery disease influences outcomes, specifically after coronary revascularization. If it does, the next step would be to investigate whether routine CMR before coronary revascularization to identify the cause of cardiomyopathy would improve the selection of patients for coronary revascularization, and overall outcomes. 

This research was supported by the National Institutes of Health [grants K23HL132011, R03HL157011, and R01HL158756]. 

For more information: www.med.umn.edu


Related Content

News | Cardiac Imaging

Nov. 13, 2024 – A recent study has demonstrated the value of the single-exposure dual-energy X-ray detector in advancing ...

Home November 13, 2024
Home
News | Cardiac Imaging

Oct. 15, 2024 — Four of the seven Medicare Administrative Contractors (MACs) have released final local coverage ...

Home October 16, 2024
Home
News | Cardiac Imaging

Oct. 15, 2024 – Elucid has announced that four of the seven Medicare Administrative Contractors (MACs) will extend ...

Home October 15, 2024
Home
News | Cardiac Imaging

PHOTO CAPTION: The Elucid PlaqueIQ user interface is a fully interactive visualization of the patient’s coronary anatomy ...

Home October 01, 2024
Home
News | Cardiac Imaging

Aug. 21, 2024 — NANO-X IMAGING LTD recently announced that its deep-learning medical imaging analytics subsidiary, Nanox ...

Home August 22, 2024
Home
News | Cardiac Imaging

July 23, 2024 — EMVision, an Australian medical device company focused on the development and commercialization of ...

Home July 23, 2024
Home
News | Cardiac Imaging

July 12, 2024 — Researchers have developed a groundbreaking method for analyzing heart MRI scans with the help of ...

Home July 12, 2024
Home
News | Cardiac Imaging

June 10, 2024 — New expert consensus from the Society of Cardiovascular Computed Tomography (SCCT) reviews previously ...

Home June 10, 2024
Home
News | Cardiac Imaging

May 10, 2024 — According to the Summa Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual ...

Home May 10, 2024
Home
News | Cardiac Imaging

April 29, 2024 — FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging ...

Home April 29, 2024
Home
Subscribe Now